Selective inhibition of Janus kinase 1 (JAK1) by filgotinib modulates the disease-associated whole blood transcriptional profile of patients with active rheumatoid arthritis
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
BMJ Publishing Group
2019
|